Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

BiTE antibody AMG 910

A half-life extended (HLE), bispecific T-cell engager (BiTE) antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 910 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	bispecific antibody AMG 910 bispecific T-cell engager AMG 910 bispecific T-cell engager antibody AMG 910
Code name:	AMG 910 AMG-910 AMG910

BiTE antibody AMG 910

Search NCI's Drug Dictionary